4218 Stock Overview
Develops, manufactures, and sells medical products and tapes in Asia and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 4218 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Nichiban Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,102.00 |
| 52 Week High | JP¥2,064.00 |
| 52 Week Low | JP¥1,688.00 |
| Beta | 0.24 |
| 1 Month Change | 9.19% |
| 3 Month Change | 9.02% |
| 1 Year Change | 21.29% |
| 3 Year Change | 17.23% |
| 5 Year Change | 15.75% |
| Change since IPO | 54.56% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4218 | JP Commercial Services | JP Market | |
|---|---|---|---|
| 7D | 5.8% | 2.2% | 3.6% |
| 1Y | 21.3% | 9.5% | 16.3% |
Return vs Industry: 4218 exceeded the JP Commercial Services industry which returned 9.5% over the past year.
Return vs Market: 4218 exceeded the JP Market which returned 16.3% over the past year.
Price Volatility
| 4218 volatility | |
|---|---|
| 4218 Average Weekly Movement | 2.2% |
| Commercial Services Industry Average Movement | 3.1% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.2% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4218 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4218's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1918 | 1,270 | Toshiaki Takatsu | www.nichiban.co.jp |
Nichiban Co., Ltd. develops, manufactures, and sells medical products and tapes in Asia and Europe. It offers medical products, including surgical tapes, wound care dressing tapes, post-operative care tapes, cornea protection tapes, and hemostatic and first-aid bandages; and sports tapes, underwraps, scissors, and bags. The company also provides curative drug for corns, calluses, and warts; Navel Compression pack, which is used for umbilical hernia compression treatment in infants; and fabric plasters, permeable film and puncture site protection dressings, absorbent hemostatic pressure dressings, and non-woven surgical tapes.
Nichiban Co., Ltd. Fundamentals Summary
| 4218 fundamental statistics | |
|---|---|
| Market cap | JP¥41.73b |
| Earnings (TTM) | JP¥2.20b |
| Revenue (TTM) | JP¥48.16b |
19.4x
P/E Ratio0.9x
P/S RatioIs 4218 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4218 income statement (TTM) | |
|---|---|
| Revenue | JP¥48.16b |
| Cost of Revenue | JP¥33.47b |
| Gross Profit | JP¥14.69b |
| Other Expenses | JP¥12.48b |
| Earnings | JP¥2.20b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 10, 2025
| Earnings per share (EPS) | 108.26 |
| Gross Margin | 30.50% |
| Net Profit Margin | 4.58% |
| Debt/Equity Ratio | 4.8% |
How did 4218 perform over the long term?
See historical performance and comparisonDividends
1.7%
Current Dividend Yield32%
Payout RatioDoes 4218 pay a reliable dividends?
See 4218 dividend history and benchmarks| Nichiban dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 27 2025 |
| Days until Ex dividend | 87 days |
| Days until Dividend pay date | 178 days |
Does 4218 pay a reliable dividends?
See 4218 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/30 14:55 |
| End of Day Share Price | 2024/12/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nichiban Co., Ltd. is covered by 5 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yusuke Miura | Daiwa Securities Co. Ltd. |
| null null | Daiwa Securities Co. Ltd. |
| Masatoshi Nagata | Ichiyoshi Research Institute Inc. |